These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15161005)

  • 1. Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors.
    Stendel R; Scheurer L; Schlatterer K; Gminski R; Möhler H
    Anticancer Res; 2004; 24(2B):631-8. PubMed ID: 15161005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of taurolidine on brain tumor cells.
    Stendel R; Stoltenburg-Didinger G; Al Keikh CL; Wattrodt M; Brock M
    Anticancer Res; 2002; 22(2A):809-14. PubMed ID: 12014655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of glioblastoma with intravenous taurolidine. First clinical experience.
    Stendel R; Picht T; Schilling A; Heidenreich J; Loddenkemper C; Jänisch W; Brock M
    Anticancer Res; 2004; 24(2C):1143-7. PubMed ID: 15154639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local chemotherapy for malignant brain tumors using methotrexate-containing fibrin glue].
    Hirakawa W; Kadota K; Asakura T; Niiro M; Yokoyama S; Hirano H; Yatsushiro K; Kubota Y; Shimodozono Y
    Gan To Kagaku Ryoho; 1995 May; 22(6):805-9. PubMed ID: 7755389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
    Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
    Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.
    Stendel R; Scheurer L; Schlatterer K; Stalder U; Pfirrmann RW; Fiss I; Möhler H; Bigler L
    Clin Pharmacokinet; 2007; 46(6):513-24. PubMed ID: 17518510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
    Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
    Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
    Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
    Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
    Nici L; Monfils B; Calabresi P
    Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
    Bobrich E; Braumann C; Opitz I; Menenakos C; Kristiansen G; Jacobi CA
    J Surg Res; 2007 Jan; 137(1):75-82. PubMed ID: 17109891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres.
    Häfeli UO; Pauer GJ; Unnithan J; Prayson RA
    Eur J Pharm Biopharm; 2007 Mar; 65(3):282-8. PubMed ID: 17129715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tranexamic acid incorporated in fibrin sealant clots on the cell behavior of neuronal and nonneuronal cells.
    Cox S; Cole M; Mankarious S; Tawil N
    J Neurosci Res; 2003 Jun; 72(6):734-46. PubMed ID: 12774314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy.
    Braumann C; Ordemann J; Kilian M; Wenger FA; Jacobi CA
    Clin Exp Metastasis; 2003; 20(5):387-94. PubMed ID: 14524527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model.
    Opitz I; Van der Veen H; Witte N; Braumann C; Mueller JM; Jacobi CA
    Eur Surg Res; 2007; 39(3):129-35. PubMed ID: 17337889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of taurolidine metabolites in healthy volunteers.
    Gong L; Greenberg HE; Perhach JL; Waldman SA; Kraft WK
    J Clin Pharmacol; 2007 Jun; 47(6):697-703. PubMed ID: 17395893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
    Rodak R; Kubota H; Ishihara H; Eugster HP; Könü D; Möhler H; Yonekawa Y; Frei K
    J Neurosurg; 2005 Jun; 102(6):1055-68. PubMed ID: 16028765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats.
    Braumann C; Menenakos C; Atanassov V; Pfirrmann RW; Guenther N; Jacobi CA
    Eur Surg Res; 2008; 40(4):341-6. PubMed ID: 18303270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.
    Braumann C; Schoenbeck M; Menenakos C; Kilian M; Jacobi CA
    Clin Exp Metastasis; 2005; 22(1):77-83. PubMed ID: 16132581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacodynamic study of mitomycin C mixed with fibrin glue for treatment of malignant brain tumors].
    Kawasaki H; Shimizu T; Takakura K; Umezawa Y
    No Shinkei Geka; 1994 Sep; 22(9):819-25. PubMed ID: 8090263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.